Technorati and Ingboo have partnered together to provide an all new kind of subscription experience for Technorati content, including search results. Look for a blue Ingboo icon for a full range of subscription options.
Feeds are also available for:
We also have channel feeds, writer feeds, and tag feeds, which can be found on their respective pages.
The Top 25 Marketers of the Year Awards are sponsored by PARADE magazine, in conjunction with the DTC National Conference, April 7-9, 2010 at the J.W. Marriott Hotel in Washington D.C.
Read the full story at http://www.prweb.com/releases/2010/02/prweb3600414.htm
Today Symfo, a leading provider of handheld electronic patient diary (EPD) products for clinical trials, announces that AstraZeneca Farmaceutica SA (Spain) has successfully completed a project using the SymPro (Symfo Patient Reported Outcome Diary) involving more than 8,500 patients, 3,000 sites, and 1,300,000 downloaded data elements. This project was part of a 12-month multi-centre international post-marketing project.
Read the full story at http://www.prweb.com/releases/2004/09/prweb159433.htm
SCIREX Corporation announced today that Robert R. Allen, M.D., has been appointed Executive Officer, Science and Medicine, Office of the President, Clinical Site Operations. In his new role as the CSO divisionÂÂs chief scientist he will be responsible for the scientific and medical oversight of studies conducted at SCIREXÂÂs clinical research sites…
Read the full story at http://www.prweb.com/releases/2005/07/prweb257131.htm
Pharmaceutical workers without cross-disciplinary skills and training are vulnerable; women, minorities, younger workers note disparity in earnings.
Read the full story at http://www.prweb.com/releases/2006/03/prweb358573.htm
Session topics at the March 12, 2008 Pharmaceutical Packaging Forum include the challenges of pharmaceutical package innovation; overall equipment effectiveness (OEE); contract packaging and anti-counterfeiting strategies.
Read the full story at http://www.prweb.com/releases/2007/10/prweb559478.htm
NetPlus Marketing, Inc., an online advertising, email and marketing agency, announces the debut of the WebÂÂs first ShoshkeleÂÂ advertising campaign for the pharmaceutical industry.
Read the full story at http://www.prweb.com/releases/2001/10/prweb29415.htm
Euroscreen S.A. has completed a license agreement with AstraZeneca UK Ltd, for access to its worldwide portfolio of CCR5 patent rights. Financial details of the agreement were not disclosed.
Read the full story at http://www.prweb.com/releases/2008/03/prweb674774.htm
Pharmaceutical sales certification, education and training — Outlook for 2006.
Read the full story at http://www.prweb.com/releases/2006/01/prweb335694.htm
Dynavax Technologies, Inc. (NASDAQ:DVAX) today announced receipt of a $4.5 million milestone payment from its partner AstraZeneca AB for the nomination of candidate drug AZD1419 for the treatment of asthma and chronic obstructive pulmonary disease (COPD). As part of this potential $136 million development and commercialization collaboration, AstraZeneca and Dynavax have initiated Investigational New Drug (IND) enabling studies with AZD1419 and plan to begin phase 1 clinical development in 2009.
Read the full story at http://www.prweb.com/releases/dynavax_technologies/clinical_development/prweb1368074.htm
WellDoc Communications, Inc., a healthcare company that develops technology solutions to help improve chronic disease management, is partnering with AstraZeneca Pharmaceuticals LP to educate patients about the importance of their medicine in asthma control. As part of its patient support program AstraZenecaâs respiratory franchise will utilize WellDocâs web- and mobile-based asthma solution, including virtual messenger, air quality and pollen count alerts as well as online patient support tools, allowing patients to manage their condition, consistent with the treatment plan of the patientâs physician, throughout their day and in real time.
Read the full story at http://www.prweb.com/releases/welldoc/patient/prweb1341024.htm
Ongoing community-based education and outreach for Medicare Part D. My Medicare Matters, which is sponsored by the National Council on Aging (NCOA) and supported through a grant from AstraZeneca Pharmaceuticals, announced today its targeted community-based education and outreach initiatives in 2007 in support of Medicare Part-D, which will include a project designed to identify and pilot innovative strategies that can help find and reach low-income seniors who may be eligible for Medicare Extra Help and other prescription savings programs.
Read the full story at http://www.prweb.com/releases/2006/12/prweb488321.htm
Recognizing that more than three million people with limited income and resources have not yet applied for the Medicare Part D prescription plan, My Medicare Matters announced its donation of technology to community organizations located within the top 100 counties where Center for Medicare Services (CMS) estimates that the remaining Medicare beneficiaries with limited resources reside.
Read the full story at http://www.prweb.com/releases/2006/12/prweb490903.htm
v-Fluence Interactive is pleased to announce the hiring of Kirsten Shae Johnson to complement the companyâs growing base of clients and research in its pharmaceutical and healthcare practice area.
Read the full story at http://www.prweb.com/releases/Online_Analytics/Pharmaceutical_Healthcare/prweb976694.htm
GenericsWeb analyses the patent landscape surrounding Anastrozole, highlighting the need for comprehensive patent information in the development of launch strategies for generic products to minimise the risk of litigation.
Read the full story at http://www.prweb.com/releases/2010/09/prweb4453654.htm
BIOWISDOM AND LINGUAMATICS TO PROVIDE AN ONTOLOGY AND NLP-BASED TEXT MINING APPLICATION TO ASTRAZENECA.
Read the full story at http://www.prweb.com/releases/2003/10/prweb86273.htm
New Partnership Kicks Off During National Nutrition Month, Bringing Simple, Low-Cholesterol Recipes Directly to Your Kitchen
Read the full story at http://www.prweb.com/releases/2011/03/prweb5162274.htm
Melior Discovery, Inc. announced today that it has signed an agreement with AstraZeneca PLC under which Meliorâs in-vivo theraTRACE® indications discovery platform will be used to evaluate the therapeutic activity of selected AstraZeneca compounds.
Read the full story at http://www.prweb.com/releases/melior/astrazeneca/prweb1226754.htm
Outsourcing manufacturing has its value, say AstraZeneca CEO David Brennan and former House Majority Leader Dick Gephardt, but can never replace the importance of in-house manufacturing expertise to a company’s ability to innovate and survive.
Read the full story at http://www.prweb.com/releases/2009/04/prweb2342114.htm
Kenney & McCafferty Represent Whistleblower Dr. Stefan Kruszewski
Read the full story at http://www.prweb.com/releases/2010/04/prweb3937374.htm
Handa Pharmaceuticals, LLC (âHandaâ), a specialty pharmaceutical company based in Fremont, California, today announced that the U.S. Food and Drug Administration (âFDAâ) has granted tentative approval of the Companyâs Abbreviated New Drug Application (âANDAâ) for Quetiapine Fumarate Extended-Release Tablets, 50 mg., 150 mg., 200 mg., 300 mg., and 400 mg., a generic version of AstraZenecaâs SEROQUEL XR®.
Read the full story at http://www.prweb.com/releases/2010/12/prweb4890534.htm
Freedland Russo is pleased that Eric Holder, U.S. Attorney General, announced the $520 million dollar settlement of a lawsuit filed against AstraZeneca (Civil Action #04-3479; US District Court, Eastern District of Pennsylvania).
Read the full story at http://www.prweb.com/releases/Freedland_Russo/AstraZeneca_settlement/prweb3934034.htm
Australia-based Astra Zeneca has received a rather large pat on the back in the form of the popular series of magazines, ‘Australia’s Best’. The company has been included in the July edition of Australia’s Best Manufacturing.
Read the full story at http://www.prweb.com/releases/2008/07/prweb1151134.htm
ExpressOn BioSystems Ltd and AstraZeneca have recently completed a contract to design small inhibitory RNA molecules (siRNAs) using ExpressOn’s ACCESSarray technology platform.
Read the full story at http://www.prweb.com/releases/2003/08/prweb75054.htm
Angel.com has deployed a number of Caller First focused inbound and outbound IVR solutions for AstraZeneca, one of the largest pharmaceutical companies in the world. This has resulted in a reduction of AstraZenecaâs cost per lead, a more cohesive customer experience, more satisfied customers and greater efficiency of their agent engagement.
Read the full story at http://www.prweb.com/releases/angelivr/astrazeneca/prweb3552844.htm
Solcara today announced that pharmaceutical giant AstraZeneca will be implementing the marketing leading press office solution, Solcara PressBureau.
Read the full story at http://www.prweb.com/releases/2006/07/prweb405795.htm
Torrent to sell stake to AstraZeneca?A possible tie-up between city-based Torrent Pharmaceutical and London-based AstraZeneca over outsourcing and co-marketing patented drugs in developing markets has led to a strong speculation of a stake sale to the UK giant.
Justices back pharmaceuticalsThe Supreme Court ruled a Calif. county can’t sue a group of drugmakers, including Pfizer , Merck , AstraZeneca , GlaxoSmithKline and Bristol-Myers Squibb , for not extending pricing pacts made with the federal gov’t to other hospital operators that receive federal funds.
Drugs group settles US tax rowASTRAZENECA, THE Anglo-Swedish pharmaceuticals group, has agreed to pay the US Internal Revenue Service $1.1 billion to settle two long-running disputes, clearing the way to greater predictability in its tax planning on both sides of the Atlantic.
AstraZeneca settles US tax dispute, raises earningsAnglo-Swedish pharmaceuticals giant AstraZeneca said Monday it had settled a tax dispute with US authorities by agreeing on a net payment of $1.1 billion (783 million euros).
Filed under: Uncategorized
Like this post? Subscribe to my RSS feed and get loads more!